Candel Therapeutics, Inc. (NASDAQ:CADL) Stock Has Consensus Price Target of $20.14 According to Brokerages

Candel Therapeutics, Inc. (NASDAQ:CADL) Stock Has Consensus Price Target of $20.14 According to Brokerages

Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold re

Guardant Health, Inc. (NASDAQ:GH) Stock Has Consensus Target Price of $188.12 According to Brokerages

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received an average rating of “Moderate Buy” from the twenty-five brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, twenty-three have issued a buy recommendation and one has given a strong buy recommendation […]